Global Dry Powder Inhaler Industry Set to Soar to US$ 29.6 Billion by 2031 with a Striking 4.6% CAGR | Forecasts FMI

Climbing to New Heights: The Global Dry Powder Inhaler Industry Anticipates Impressive 4.6% CAGR Growth from 2021 to 2031, Envisioning a Market Valued at Approximately US$ 18.9 Billion in 2021. Future Market Insights’ Projections Highlight the Dominance of Manually Operated Inhaler Devices, Commanding a Significant 70.9% Share of the Global Dry Powder Inhaler Industry in 2021.

Challenges Regarding Varying Characteristics of Dry Powder Inhalers to Pave Opportunities for Medical Device Manufacturers

Regulatory pressures and changes in the drug delivery market have driven the innovation of the dry powder inhaler forward.

Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5150

According to the World Health Organization (WHO), nearly 300 Mn people worldwide are affected by asthma, and approximately 240 Mn by chronic obstructive pulmonary disease (COPD).

Over half of these patients combined prefer the use of dry powder inhalers for the treatment of their disease.

These devices have depicted great potential in effective and reliable drug delivery, with novel designs ensuring the possibility to overcome future compliance, cost, and safety challenges.

Some of the essential performance characteristics regarding dry powder inhalers are associated with dose delivery, performances at varying airflows, and fine particle fraction content.

These characteristics may vary for powder formulations, creating the need for fine-tuning of the device or powder formulation or both combined for achieving optimal performance.

The requirement is particularly high in micro-dosing dry powder inhalers, which in turn is paving opportunities for medical device manufacturers in terms of innovations and advancements.

Growing adoption of unhealthy lifestyles, increasing geriatric population, and growing air pollution levels fuelling the prevalence of various respiratory disorders are key factors driving the expansion of the global powder inhaler market.

In addition, favorable government initiatives being taken across the globe to improve the healthcare infrastructure will further influence the market growth.

Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5150

However, the fact that dry powder inhalers are not moisture-resistant remains a major challenge for manufacturers, as the medicine loses its properties when it comes in contact with moisture.

The availability of effective alternatives such as nebulizers and electric pumps is expected to restrain the adoption of dry powder inhalers.

Lack of awareness regarding these devices in low-income & underdeveloped countries may further hinder the market growth to a certain extent.

Key Research Findings from FMI’s Report on Global Dry Powder Inhaler Industry

• North America will continue to be the most lucrative region for the growth of the Global Dry Powder Inhaler Industry. Dry powder inhaler sales in the region will register the fastest expansion through 2031. Asia-Pacific excluding Japan (APEJ) is expected to be the second largest market for dry powder inhalers.
• Hospital pharmacies will continue to be the leading distribution channel for dry powder inhalers, with sales pegged to surpass 150,000 Mn units by 2031-end.
• Dry powder inhalers will continue to observe the largest application in the treatment of asthma, followed by chronic obstructive pulmonary disease. In addition, sales of dry powder inhalers for application in the treatment of asthma and pulmonary arterial hypertension are slated to exhibit a parallel growth through 2031.

Leading companies in the Global Dry Powder Inhaler Industry are focusing on the development of new-generation products.

These market players are making huge investments in R&D activities associated with novel device architectures, particle engineering, and powder formulations.

Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/5150

Key Market Segments Covered In Global Dry Powder Inhaler Industry Research

By Product:

• Single Dose Dry Powder Inhalers
• Multi-Dose Dry Powder Inhalers

By Indication:

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Pulmonary Arterial Hypertension
• Diabetes
• Cystic Fibrosis

By Function:

• Manually Operated Inhaler Devices
• Digitally Operated Inhaler Devices

By End User:

• Institutional Sales
  • Hospital Pharmacies
  • Cancer Research
  • Office-based Speciality Clinics
• Retail Sales
  • Retail Pharmacies
  • Drug Stores
• Mail Order Pharmacies

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube